Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
14.71
Price to sales ratio
3.93

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1158
LNTH
Lantheus Holdings, Inc. - Common Stock
100.77 USD+0.30%+0.67%-1.94%+79.75%6.58 B USD
1274
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
17.54 USD-2.61%-1.79%-4.88%+66.26%5.60 B USD
1795
RGC
Regencell Bioscience Holdings Limited - Ordinary Shares
5.50 USD-0.36%+3.77%-9.24%-60.46%2.72 B USD
1841
SUPN
Supernus Pharmaceuticals, Inc. - Common Stock
43.73 USD-1.04%-4.62%-13.32%-19.02%2.54 B USD

Frequently asked questions about Indivior Pharmaceuticals, Inc. Common Stock

What is the Indivior Pharmaceuticals, Inc. Common Stock stock price today?

The current price of Indivior Pharmaceuticals, Inc. Common Stock (INDV) is 34.87. Over the past 24 hours, the stock has changed by -1.22%. Follow the INDV chart for real-time price dynamics.

What is the stock ticker of Indivior Pharmaceuticals, Inc. Common Stock?

Indivior Pharmaceuticals, Inc. Common Stock trades under the ticker INDV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Indivior Pharmaceuticals, Inc. Common Stock stock going up?

INDV has changed by -4.54% over the last week, -13.50% over the last month, and +3.78% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Indivior Pharmaceuticals, Inc. Common Stock?

Indivior Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 4.12 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Indivior Pharmaceuticals, Inc. Common Stock earnings last quarter?

Last quarter, Indivior Pharmaceuticals, Inc. Common Stock reported earnings of 1.02 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Indivior Pharmaceuticals, Inc. Common Stock revenue for the last quarter?

Indivior Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 343 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Indivior Pharmaceuticals, Inc. Common Stock net income for the last quarter?

Indivior Pharmaceuticals, Inc. Common Stock reported net income of 122 M for the last quarter. The previous quarter showed 89 M, which means net income changed by +37.08%.

How many employees does Indivior Pharmaceuticals, Inc. Common Stock have?

As of the latest available data, Indivior Pharmaceuticals, Inc. Common Stock has 838 employees. Workforce size can provide additional context about the company's scale and operations.

What is Indivior Pharmaceuticals, Inc. Common Stock EBITDA?

Indivior Pharmaceuticals, Inc. Common Stock EBITDA is 161 M, and its EBITDA margin is 46.94%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Indivior Pharmaceuticals, Inc. Common Stock stock?

You can buy Indivior Pharmaceuticals, Inc. Common Stock (INDV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Indivior Pharmaceuticals, Inc. Common Stock stock?

Investing in Indivior Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INDV chart and related analysis on metatrader.com as part of your research.

Indivior Pharmaceuticals, Inc. - Common Stock

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

News